Company profile
NurExone Biologic Inc.
OTC: NRXBF · Healthcare · Biotechnology
Canadian filerHQ Toronto, ONReports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 32
v0.1 · 5/100 weight · pillars only
↑ market scale, workforce scale · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
—
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
16
as of 2026-09-04
Market cap
$30.8M
as of 2026-09-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NurExone Biologic Inc.’s financial profile?
NurExone Biologic Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Sernova Corp.——Tevogen Bio Holdings Inc.——MIRA Pharmaceuticals, Inc.——Cell Source, Inc.——Vicapsys Life Sciences, Inc.——LeonaBio, Inc.——Key facts
CEOLior Shaltiel
SectorHealthcare
IndustryBiotechnology
HeadquartersToronto, ON
ExchangeOTC: NRXBF
Employees16
IPO date2023-11-10
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.